IRIS
CELLE, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.025
Totale 5.025
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.025
Totale 5.025
Salva come PNG Salva come JPEG
Città #
Genova 3.977
Rapallo 530
Genoa 399
Vado Ligure 119
Totale 5.025
Salva come PNG Salva come JPEG
Nome #
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. 176
Time pattern of gastric acidity in Barrett's esophagus 152
Circadian monitoring of gastric juice mutagenicity. 139
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 129
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 127
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 127
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 123
Acid and gastric metaplasia in the duodenum 122
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 122
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 115
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 115
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 113
Anti-helicobacter regimens 111
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 111
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 106
Helicobacter pylori eradication and reinfection 105
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 104
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 103
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 102
Gastric metaplasia and Helicobacter pylori infection. 101
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use 100
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 99
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 98
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 97
COMPARATIVE EFFECTS OF CHEENODEOXYCHOLIC (CDCA) AND URSODEOXYCHOLIC ACID (UDCA) IN PREGNAT RATS. 96
Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs 95
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 94
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 92
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. 92
Duodenal ulcer resistant to usual omeprazole dose. 90
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 88
Duration of acid suppression in H2-antagonist nonresponders. 86
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 85
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. 84
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. 84
Ulcer heterogeneity: further arguments for a range of antisecretory treatment. 83
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. 83
Chenodeoxycholic acid (CDCA) versus ursodeoxycholic (UDCA): a comparison of their effects in pregnant rats. 82
Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. 82
Pharmacodynamics of famotidine in gastric ulcer. 81
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 81
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 79
Helicobacter pylori and NSAID-induced ulcers. 77
Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. 76
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. 76
Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. 74
Circadian acidity pattern in gastric ulcers at different sites. 72
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? 71
Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. 63
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. 60
Acid inhibition and amoxicillin activity against Helicobacter pylori. 59
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. 43
Totale 5.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.229
article - articoli 10.581
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 2.648
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.242 0 0 0 64 134 134 230 80 124 246 158 72
2020/2021278 22 24 20 27 16 15 19 22 38 40 15 20
2021/2022554 20 47 32 86 11 45 55 93 22 61 18 64
2022/2023638 68 47 8 58 122 100 0 40 106 5 76 8
2023/2024261 9 29 6 28 18 40 7 17 28 3 28 48
2024/2025149 43 74 25 7 0 0 0 0 0 0 0 0
Totale 5.025